Response to the communication of M Hosp et al. on low-cost progression markers in HIV-1 seropositive Zambians

HIV Med. 2001 Jan;2(1):61. doi: 10.1046/j.1468-1293.2001.00050.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Biomarkers
  • Disease Progression
  • HIV Infections / diagnosis*
  • HIV-1*
  • Humans
  • Lymphocyte Count / economics*
  • Medically Underserved Area*
  • Zambia

Substances

  • Biomarkers